Search - tctmd.com

Displaying 541 - 560 of 643

Sort: Relevancy | Date

Presentation TVT 2014

Coronary Occlusion After TAVR: Review from a Multicenter Experience

Presenter: Jean-Michel Paradis

June 07, 2014

Presentation TVT 2014

BleedingEarly and LateAfter TAVR: Often Misunderstood and Neglected

Presenter: Philippe Généreux

June 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation TVT 2014

Management of Major Transfemoral Access Site Complications: Toolbox, Techniques, and Case Examples

Presenter: Mathew Williams

June 07, 2014

Presentation TVT 2014

Transfemoral TAVR Access Site Complications: Lessons from the Published Literature

Presenter: Philippe Généreux

June 07, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Conference News EuroPCR 2014

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Caitlin E. Cox

May 22, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

L.A. McKeown

March 13, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Jason Kahn

March 06, 2014

Presentation

Managing Vascular Access for TAVR: Preventing and Handling Complications

Presenter: Curtiss T. Stinis

February 05, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

Fever After TAVR Common, but Antibiotics Rarely Needed

L.A. McKeown

January 15, 2014

News Daily News

La Fiebre tras la TAVR es Común aunque los Antibióticos No suelen ser Necesarios

L.A. McKeown

January 15, 2014

News Daily News

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Jason Kahn

January 01, 2014

Advertisement

Coronary Occlusion After TAVR: Review from a Multicenter Experience

BleedingEarly and LateAfter TAVR: Often Misunderstood and Neglected

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Management of Major Transfemoral Access Site Complications: Toolbox, Techniques, and Case Examples

Transfemoral TAVR Access Site Complications: Lessons from the Published Literature

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Managing Vascular Access for TAVR: Preventing and Handling Complications

Medtronic CoreValve® System Obtains Early FDA Approval

Fever After TAVR Common, but Antibiotics Rarely Needed

La Fiebre tras la TAVR es Común aunque los Antibióticos No suelen ser Necesarios

PARTNER: 外科手术与TAVR相比, 出血情况更普遍、更危险

PARTNER: Hemorragias Más Prevalentes y Peligrosas con la Cirugía que con la TAVR

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content